Optimal choice of the number of treatments to be included in a clinical trial

Nigel Stallard, Martin Posch, Tim Friede, Franz Koenig, Werner Brannath

Type: Article

Publication Date: 2009-02-26

Citations: 15

DOI: https://doi.org/10.1002/sim.3551

View Publication

Locations

PubMed - View
Statistics in Medicine - View

Similar Works

Action	Title	Year	Authors
+	Optimal sample sizes for phase II clinical trials and pilot studies	2011	Nigel Stallard
+	Designing a series of clinical trials	2012	Siew Wan Hee
+ PDF Chat	Statistical challenges in assessing potential efficacy of complex interventions in pilot or feasibility studies	2015	Duncan T. Wilson Rebecca Walwyn Julia Brown Amanda Farrin Sarah Brown
+ PDF Chat	Bayesian methods for the design and interpretation of clinical trials in very rare diseases	2014	Lisa V. Hampson John Whitehead Despina Eleftheriou Paul Brogan
+	A more powerful test for three-arm non-inferiority via risk difference: Frequentist and Bayesian approaches	2021	Erina Paul Ram C. Tiwari Shrabanti Chowdhury Samiran Ghosh
+ PDF Chat	Bayesian Designs and the Control of Frequentist Characteristics: A Practical Solution	2014	Steffen Ventz Lorenzo Trippa
+ PDF Chat	Optimizing the data combination rule for seamless phase II/III clinical trials	2014	Lisa V. Hampson Christopher Jennison
+	Decision‐Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies	2003	Nigel Stallard
+	A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority	2007	Yongzhao Shao Vandana Mukhi Judith D. Goldberg
+	A Bayesian Approach to Assessing the Superiority of a Dose Combination	1998	Melinda A. Miller John W. Seaman
+	Some practical considerations in three‐arm non‐inferiority trial design	2016	Ming Zhou Sudeep Kundu
+	Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons	2013	Quality
+ PDF Chat	Bayesian sample sizes for exploratory clinical trials comparing multiple experimental treatments with a control	2015	John Whitehead Faye Cleary Amanda Turner
+	R software to accompany "Bayesian methods for the design and interpretation of clinical trials in very rare diseases".	2014	Lisa V. Hampson John Whitehead
+	Sample size determination for a binary response in a superiority clinical trial using a hybrid classical and Bayesian procedure	2017	Maria Ciarleglio Christopher D. Arendt
+	The choice of sample size: a mixed Bayesian / frequentist approach	2008	Hamid Pezeshk Nader Nematollahi Vahed Maroufy John Gittins
+ PDF Chat	A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials	2021	Kevin Kunzmann Michael J. Grayling Kim May Lee David S. Robertson Kaspar Rufibach James Wason
+	A Bayesian cost-benefit approach to sample size determination and evaluation in clinical trials	2011	John Gittins
+ PDF Chat	Theory and practical use of Bayesian methods in interpreting clinical trial data: a narrative review	2020	David Ferreira Maël Barthoulot Julien Pottecher Klaus D. Torp Pierre Diemunsch Nicolás Meyer
+	Adaptive clinical trials: Bayesian decision-theoretic and frequentist approaches for cost-effectiveness analysis	2020	Martin Förster Marco Novelli

Works That Cite This (13)

Action	Title	Year	Authors
+	On the choice of doses for phase III clinical trials	2012	Vera Lisovskaja Carl‐Fredrik Burman
+ PDF Chat	Adaptive designs for subpopulation analysis optimizing utility functions	2014	Alexandra Gráf Martin Posch Franz Koenig
+ PDF Chat	Single‐stage, three‐arm, adaptive test strategies for non‐inferiority trials with an unstable reference	2022	Werner Brannath Martin Scharpenberg Sylvia Schmidt
+ PDF Chat	To add or not to add a new treatment arm to a multiarm study: A decision‐theoretic framework	2019	Kim May Lee James Wason Nigel Stallard
+	Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods	2012	Peter Kimani Ekkehard Glimm Willi Maurer Jane L. Hutton Nigel Stallard
+ PDF Chat	Improving adaptive seamless designs through Bayesian optimization	2022	Jakob Richter Tim Friede Jörg Rahnenführer
+	Collaborative Platform Trials to Fight COVID‐19: Methodological and Regulatory Considerations for a Better Societal Outcome	2021	Olivier Collignon Carl‐Fredrik Burman Martin Posch Anja Schiel
+ PDF Chat	Optimizing subgroup selection in two‐stage adaptive enrichment and umbrella designs	2021	Nicolás Ballarini Thomas Burnett Thomas Jaki Christoper Jennison Franz König Martin Posch
+ PDF Chat	Decision-theoretic designs for small trials and pilot studies: A review	2015	Siew Wan Hee Thomas Hamborg Simon Day Jason Madan Frank Miller Martin Posch Sarah Zohar Nigel Stallard
+	Optimal design of clinical trials with biologics using dose‐time‐response models	2014	Markus R. Lange Heinz Schmidli

Works Cited by This (38)

Action	Title	Year	Authors
+	Statistical Methods for Combining Clinical Trial Phases II And III	2007	Nigel Stallard Susan Todd
+	A Sample-Size-Optimal Bayesian Procedure for Sequential Pharmaceutical Trials	1994	Noel Cressie Jonathan Biele
+ PDF Chat	Optimum treatment allocation rules under a variance heterogeneity model	2008	Weng Kee Wong Wei Zhu
+	Combining different phases in the development of medical treatments within a single trial	1999	Péter Bauer Meinhard Kieser
+	Designed Extension of Studies Based on Conditional Power	1995	Michael A. Proschan Sally Hunsberger
+	Adaptive Dunnett tests for treatment selection	2007	Franz Koenig Werner Brannath Frank Bretz Martin Posch
+	A Comparison of Methods for Adaptive Treatment Selection	2008	Tim Friede Nigel Stallard
+	A Multiple Comparison Procedure for Comparing Several Treatments with a Control	1955	Charles W. Dunnett
+	Robustness of Multiple Comparison Procedures: Treatment versus Control	1988	Paul Rudolph
+	A group‐sequential design for clinical trials with treatment selection	2008	Nigel Stallard Tim Friede